These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5333963)

  • 1. L-asparaginase: toxicity to normal and leukemic human lymphocytes.
    Schrek R; Dolowy WC; Ammeraal RN
    Science; 1967 Jan; 155(3760):329-30. PubMed ID: 5333963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro test for sensitivity of leukemic cells to L-asparaginase.
    Schrek R; Dolowy WC
    Cancer Res; 1971 May; 31(5):523-6. PubMed ID: 4932205
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition by ionophore A23187 of the cytotoxicity of vincristine, colchicine and X-rays to leukemic lymphocytes.
    Schrek R; Stefani SS
    Oncology; 1976; 33(3):132-5. PubMed ID: 796774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity of L-asparaginase to resistant and susceptible lymphoma cells in vitro.
    Dolowy WC; Elrod LM; Ammeraal RN; Schrek R
    Proc Soc Exp Biol Med; 1967 Jun; 125(2):598-601. PubMed ID: 5339205
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppression of murine leukemias by L-asparaginase. Incidence of sensitivity among leukemias of various types: comparative inhibitory activities of guinea pig serum L-asparaginase and Escherichia coli L-asparaginase.
    Boyse EA; Old LJ; Campbell HA; Mashburn LT
    J Exp Med; 1967 Jan; 125(1):17-31. PubMed ID: 5334543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of lymphocytic blastogenesis in vitro with asparaginase in normal and leukemic subjects].
    Calabri G; Gatta A; Guazzelli C
    Haematologica; 1969; 54(12):890-8. PubMed ID: 4993255
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action of a guinea pig serum asparaginase preparation on normal and leukemic mouse lymphocytes].
    Kastrikin NF
    Patol Fiziol Eksp Ter; 1972; 16(5):79-80. PubMed ID: 4670459
    [No Abstract]   [Full Text] [Related]  

  • 8. Asparaginase and amino acids in cancer therapeutics. Cancer and Leukemia Group B Investigators.
    Holland JF; Ohnuma T
    Cancer Treat Rep; 1981; 65 Suppl 4():123-30. PubMed ID: 7049376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary studies on the treatment of acute lymphocytic leukemia of the child with L-asparaginase].
    Astaldi G; Burgio GR; Severi F; Genova R; Curtoni E; Bruschelli M; Astaldi AA
    Haematol Lat; 1968; 11(4):311-47. PubMed ID: 4899936
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunologic memory of the normal and the leukemic lymphocyte.
    Brody JI; Oski F
    Ann Intern Med; 1967 Sep; 67(3):573-8. PubMed ID: 5342814
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of HeLa cell cultures by preparations of Escherichia coli L-asparaginase.
    Kim JH; Boyse EA; Old LJ; Campbell HA
    Biochim Biophys Acta; 1968 Jun; 158(3):476-9. PubMed ID: 4873181
    [No Abstract]   [Full Text] [Related]  

  • 12. Multicomponent analysis of amino acid transport in human lymphocytes. Diminished L-system transport in chronic leukemic B lymphocytes.
    Segel GB; Simon W; Lichtman MA
    J Clin Invest; 1984 Jul; 74(1):17-24. PubMed ID: 6610691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity of anti-dog lymphocyte serum to normal and leukemic human lymphocytes.
    Schrek R; Preston FW; Dietz AA
    Blood; 1969 Apr; 33(4):555-63. PubMed ID: 4887383
    [No Abstract]   [Full Text] [Related]  

  • 14. In-vitro cytotoxicity of L-asparaginase on rodent and human neoplastic cells.
    Schrek R; Dolowy WC
    Lancet; 1970 Oct; 2(7675):722. PubMed ID: 4195957
    [No Abstract]   [Full Text] [Related]  

  • 15. Differences between lymphocytes of leukemic and non-leukemic patients with respect to morphologic features, motility, and sensitivity to guinea pig serum.
    SCHREK R; DONNELLY WJ
    Blood; 1961 Nov; 18():561-71. PubMed ID: 13909290
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of cortisol on the ultrastructure of normal, leukemic, and cultured human lymphocytes.
    Werthamer S; Amaral L
    In Vitro; 1975; 11(4):212-23. PubMed ID: 1176157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of L-asparaginase in lymphocyte transformation induced by phytohemagglutinin.
    Miura M; Hirano M; Kakizawa K; Morita A; Uetani T; Yamada K
    Cancer Res; 1970 Mar; 30(3):768-72. PubMed ID: 4912944
    [No Abstract]   [Full Text] [Related]  

  • 18. Zinc uptake in normal and leukemic lymphocytes: effect of poly-L-ornithine.
    Phillips JL; Tuley JA; Bowman RP
    J Natl Cancer Inst; 1977 May; 58(5):1229-31. PubMed ID: 853523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivity of B leukemic lymphocytes of patients with chronic lymphocytic leukemia to PWM and PHA.
    Isaković K; Lenert G
    Blood Cells; 1987; 12(2):355-64. PubMed ID: 3497681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered mitogenic responsiveness of chronic leukemic lymphocytes and normal human lymphocytes treated with dimethyl sulfoxide.
    Dennis AJ; Wilson HE
    Ann N Y Acad Sci; 1975 Jan; 243():73-80. PubMed ID: 1055567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.